197
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Screening the “Invisible Population” of Older Adult Patients for Prescription Pain Reliever Non-Medical Use and Use Disorders

ORCID Icon, , ORCID Icon, &

References

  • Ali, R., Meena, S., Eastwood, B., Richards, I., & Marsden, J. (2013). Ultra-rapid screening for substance-use disorders: The alcohol, smoking and substance involvement screening test (ASSIST-lite). Drug and Alcohol Dependence, 132(1–2), 352–361. https://doi.org/10.1016/j.drugalcdep.2013.03.001
  • AssistPortal. (n.d.) AssistPortal: A bit about you. Retrieved from https://eassist.assistportal.com.au/#/eassist-lite
  • Association of American Medical Colleges (AAMC). (2022). Curriculum reports. Retrieved from https://www.aamc.org/data-reports/curriculum-reports/interactive-data/opioid-addiction-content-required-curriculum
  • Austin, E. J., Briggs, E. S., Ferro, L., Barry, P., Heald, A., Curran, G. M., Saxon, A. J., Fortney, J., Ratzliff, A. D., & Williams, E. C. (2022). Integrating routine screening for opioid use disorder into primary care settings: Experiences from a National cohort of clinics. Journal of General Internal Medicine, 1–9. https://doi.org/10.1007/s11606-022-07675-2
  • Cacciola, J. S., Alterman, A. I., Dephilippis, D., Drapkin, M. L., Valadez, C., Jr, Fala, N. C., Oslin, D., & McKay, J. R. (2013). Development and initial evaluation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263. https://doi.org/10.1016/j.jsat.2012.07.013
  • Center for Substance Abuse Treatment (CSAT). (1997). A guide to substance abuse services for primary care clinicians. Rockville (MD): Substance abuse and mental health services administration (US); 1997. (Treatment Improvement Protocol (TIP) Series, No. 24.) Chapter 2—Screening for Substance Use Disorders. Available from: https://www.ncbi.nlm.nih.gov/books/NBK64820/
  • Centers for Disease Control and Prevention (CDC). (2020). Opioids: Interactive training series. Retrieved from https://www.cdc.gov/opioids/providers/training/interactive.html
  • Chang, Y. P. (2018). Factors associated with prescription opioid misuse in adults aged 50 or older. Nursing Outlook, 66(2), 112–120. https://doi.org/10.1016/j.outlook.2017.10.007
  • Choi, N. G., DiNitto, D. M., & Marti, C. N. (2014). Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults. Drug and Alcohol Dependence, 145, 113–120. https://doi.org/10.1016/j.drugalcdep.2014.10.004
  • Cicero, T. J., Surratt, H. L., Kurtz, S., Ellis, M. S., & Inciardi, J. A. (2012). Patterns of prescription opioid abuse and comorbidity in an aging treatment population. Journal of Substance Abuse Treatment, 42(1), 87–94. https://doi.org/10.1016/j.jsat.2011.07.003
  • Coalition on Physician Education in Substance Use Disorders (COPE). (2021). About COPE. Retrieved April 11, 2022 from https://www.copenow.org/about-cope/
  • Dahlhamer, J., Lucas, J., Zelaya, C., Nahin, R., Mackey, S., DeBar, L., Kerns, R., Von Korff, M., Porter, L., & Helmick, C. (2018). Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. Morbidity and Mortality Weekly Report, 67(36), 1001–1006. https://doi.org/10.15585/mmwr.mm6736a2
  • Fenton, J. J., Magnan, E., Tseregounis, I. E., Xing, G., Agnoli, A. L., & Tancredi, D. J. (2022). Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering. JAMA network open, 5(6), e2216726. https://doi.org/10.1001/jamanetworkopen.2022.16726
  • Ford, J. A., Schepis, T. S., & McCabe, S. E. (2021). Poly-prescription drug misuse across the life course: Prevalence and correlates across different adult age cohorts in the U.S. The International Journal on Drug Policy, 88, 103017. https://doi.org/10.1016/j.drugpo.2020.103017
  • Gonzalez, C. M., Deno, M. L., Kintzer, E., Marantz, P. R., Lypson, M. L., & McKee, M. D. (2019). A qualitative study of New York medical student views on implicit bias instruction: Implications for curriculum development. Journal of General Internal Medicine, 34(5), 692–698. https://doi.org/10.1007/s11606-019-04891-1
  • Han, B. H. (2018). Aging, multimorbidity, and substance use disorders: The growing case for integrating the principles of geriatric care and harm reduction. The International Journal on Drug Policy, 58, 135–136. https://doi.org/10.1016/j.drugpo.2018.06.005
  • Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National survey on drug use and health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
  • Han, B. H., & Moore, A. A. (2018). Prevention and screening of unhealthy substance use by older adults. Clinics in Geriatric Medicine, 34(1), 117–129. https://doi.org/10.1016/j.cger.2017.08.005
  • Humeniuk, R. E., Henry-Edwards, S., Ali, R. L., Poznyak, V., & Monteiro, M. (2010). The alcohol, smoking and substance involvement screening test (ASSIST): Manual for use in primary care. World Health Organization.
  • Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009). Interventions that can reduce inappropriate prescribing in the elderly: A systematic review. Drugs & Aging, 26(12), 1013–1028. https://doi.org/10.2165/11318890-000000000-00000
  • Konkle-Parker, D., Williams, D., McAfee, N., Schumacher, J. A., & Parker, J. (2022). Low-burden universal substance use screening in a primary care clinic to lower implementation barriers. The Journal of Behavioral Health Services & Research, 1–11. https://doi.org/10.1007/s11414-022-09814-3
  • Kuerbis, A. (2020). Substance use among older adults: An update on prevalence, etiology, assessment, and intervention. Gerontology, 66(3), 249–258. https://doi.org/10.1159/000504363
  • Kuerbis, A., Sacco, P., Blazer, D. G., & Moore, A. A. (2014). Substance abuse among older adults. Clinics in Geriatric Medicine, 30(3), 629–654. https://doi.org/10.1016/j.cger.2014.04.008
  • Levy, S. R. (2018). Toward reducing ageism: PEACE (Positive Education about Aging and Contact Experiences) model. The Gerontologist, 58(2), 226–232. https://doi.org/10.1093/geront/gnw116
  • Lo-Ciganic, W. H., Huang, J. L., Zhang, H. H., Weiss, J. C., Kwoh, C. K., Donohue, J. M., Gordon, A. J., Cochran, G., Malone, D. C., Kuza, C. C., & Gellad, W. F. (2020). Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. PloS One, 15(7), e0235981. https://doi.org/10.1371/journal.pone.0235981
  • Maree, R. D., Marcum, Z. A., Saghafi, E., Weiner, D. K., & Karp, J. F. (2016). A systematic review of opioid and benzodiazepine misuse in older adults. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 24(11), 949–963. https://doi.org/10.1016/j.jagp.2016.06.003
  • Mason, M., Soliman, R., Kim, H. S., & Post, L. A. (2022). Disparities by sex and race and ethnicity in death rates due to opioid overdose among adults 55 years or older, 1999 to 2019. JAMA Network Open, 5(1), e2142982. https://doi.org/10.1001/jamanetworkopen.2021.42982
  • McCabe, S. E., Wilens, T. E., Boyd, C. J., Chua, K. P., Voepel-Lewis, T., & Schepis, T. S. (2019). Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States. Addictive Behaviors, 90, 285–293. https://doi.org/10.1016/j.addbeh.2018.11.010
  • McNeely, J., Adam, A., Rotrosen, J., Wakeman, S. E., Wilens, T. E., Kannry, J., Rosenthal, R. N., Wahle, A., Pitts, S., Farkas, S., Rosa, C., Peccoralo, L., Waite, E., Vega, A., Kent, J., Craven, C. K., Kaminski, T. A., Firmin, E., Isenberg, B., … Hamilton, L. (2021). Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics. JAMA Network Open, 4(5), e2110721. https://doi.org/10.1001/jamanetworkopen.2021.10721
  • McNeely, J., Kumar, P. C., Rieckmann, T., Sedlander, E., Farkas, S., Chollak, C., Kannry, J. L., Vega, A., Waite, E. A., Peccoralo, L. A., Rosenthal, R. N., McCarty, D., & Rotrosen, J. (2018). Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: A qualitative study of patients, providers, and staff. Addiction Science & Clinical Practice, 13(1), 8. https://doi.org/10.1186/s13722-018-0110-8
  • McNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., O’Grady, K. E., Bouk, L. B., Cushing, C., King, J., Wahle, A., & Schwartz, R. P. (2016). Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Annals of Internal Medicine, 165(10), 690–699. https://doi.org/10.7326/M16-0317
  • Muzyk, A., Smothers, Z., Akrobetu, D., Ruiz Veve, J., MacEachern, M., Tetrault, J. M., & Gruppen, L. (2019). Substance use disorder education in medical schools: A scoping review. Academic Medicine: Journal of the Association of American Medical Colleges, 94(11), 1825–1834. https://doi.org/10.1097/ACM.0000000000002883
  • National Institute on Drug Abuse (NIDA). (2014). CoE overview. Retrieved from https://nida.nih.gov/nidamed-medical-health-professionals/health-professions-education/centers-excellence/coe-overview
  • National Institute on Drug Abuse (NIDA). (2017). Curriculum resources overview. Retrieved from https://nida.nih.gov/nidamed-medical-health-professionals/health-professions-education/centers-excellence/curriculum-resources-overview
  • National Institute on Drug Abuse (NIDA). (n.d.a). Nida quick screen V1.0—National institute on drug abuse. Retrieved from https://nida.nih.gov/sites/default/files/pdf/nmassist.pdf
  • National Institute on Drug Abuse (NIDA). (2022, May 10). Overview. Retrieved from. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview
  • National Institute on Drug Abuse (NIDA). (2012). Resource guide: Screening for drug use in general medical settings. Retrieved from https://archives.drugabuse.gov/publications/resource-guide-screening-drug-use-in-general-medical-settings on 2022, April 9.
  • National Institute on Drug Abuse (NIDA). (n.d.b). Screening for drug use in general medical settings—Resource guide. Retrieved from https://nida.nih.gov/sites/default/files/resource_guide.pdf
  • “NIDA quick screen & NIDA-modified alcohol, smoking, and substance involvement screening test (NM-ASSIST).” (n.d.).Substance use screening tools for HIV service delivery settings. Retrieved from https://ssc.jsi.com/sites/default/files/2021-03/NM-ASSIST_508.pdf
  • Odani, S., Lin, L. C., Nelson, J. R., & Agaku, I. T. (2020). Misuse of prescription pain relievers, stimulants, tranquilizers, and sedatives among U.S. older adults aged ≥50 years. American Journal of Preventive Medicine, 59(6), 860–872. https://doi.org/10.1016/j.amepre.2020.04.028
  • Olfson, M., Wang, S., Iza, M., Crystal, S., & Blanco, C. (2013). National trends in the office-based prescription of schedule II opioids. The Journal of Clinical Psychiatry, 74(9), 932–939. https://doi.org/10.4088/JCP.13m08349
  • Patterson, T. L., & Jeste, D. V. (1999). The potential impact of the baby-boom generation on substance abuse among elderly persons. Psychiatric Services (Washington, D.C.), 50(9), 1184–1188. https://doi.org/10.1176/ps.50.9.1184
  • Samra, R., Cox, T., Gordon, A. L., Conroy, S. P., Lucassen, M., & Griffiths, A. (2017). Factors related to medical students’ and doctors’ attitudes towards older patients: A systematic review. Age and Ageing, 46(6), 911–919. https://doi.org/10.1093/ageing/afx058
  • Schepis, T. S., Klare, D. L., Ford, J. A., & McCabe, S. E. (2020b). Prescription drug misuse: Taking a lifespan perspective. Substance Abuse: Research and Treatment, 14, 1178221820909352. https://doi.org/10.1177/1178221820909352
  • Schepis, T. S., & McCabe, S. E. (2016). Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002–2003 and 2012–2013 National survey on drug use and health. Addictive Behaviors, 60, 219–222. https://doi.org/10.1016/j.addbeh.2016.04.020
  • Schepis, T. S., McCabe, S. E., & Ford, J. A. (2022). Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex. The American Journal on Addictions, 31(5), 396–402. https://doi.org/10.1111/ajad.13289 https://doi.org/10.1111/ajad.13289
  • Shoff, C., Yang, T. C., & Shaw, B. A. (2021). Trends in opioid use disorder among older adults: Analyzing medicare data, 2013–2018. American Journal of Preventive Medicine, 60(6), 850–855. https://doi.org/10.1016/j.amepre.2021.01.010
  • Simoni-Wastila, L., & Yang, H. K. (2006). Psychoactive drug abuse in older adults. The American Journal of Geriatric Pharmacotherapy, 4(4), 380–394. https://doi.org/10.1016/j.amjopharm.2006.10.002
  • Substance Abuse and Mental Health Services Administration (US) (SAMHSA) and Office of the Surgeon General (US). (2016). Facing addiction in America: The surgeon general’s report on alcohol, drugs, and health [Internet]. Washington (DC): US Department of Health and Human Services; 2016 Nov. Chapter 4, Early intervention, treatment, and management of substance use disorders. Available from: https://www.ncbi.nlm.nih.gov/books/NBK424859/
  • Substance Abuse and Mental Health Services Administration (US) (SAMHSA). (2020). Treating substance use disorder in older adults. Treatment Improvement Protocol (TIP) Series No. 26, SAMHSA Publication No. PEP20-02-01-011. MD: Substance Abuse and Mental Health Services Administration.
  • US Census Bureau. (2020, June 25). 65 and older population grows rapidly as baby boomers age. [Press release]. https://www.census.gov/newsroom/press-releases/2020/65-older-population-grows.html
  • US Department of Health and Human Services. (n.d.). Tobacco, alcohol, prescription medication, and other substance use (TAPS) tool. National Institutes of Health. Retrieved from https://nida.nih.gov/taps2/
  • US Department of Veterans Affairs (VHA). (2014, January 16). Veterans affairs. VA Center for Integrated Healthcare (CIH). Retrieved from https://www.mirecc.va.gov/cih-visn2/
  • Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Donahue, K., Doubeni, C. A., Epling, J. W., Jr, Kubik, M., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2020). Screening for unhealthy drug use: US preventive services task force recommendation statement. JAMA, 323(22), 2301–2309. https://doi.org/10.1001/jama.2020.8020
  • West, N. A., Severtson, S. G., Green, J. L., & Dart, R. C. (2015). Trends in abuse and misuse of prescription opioids among older adults. Drug and Alcohol Dependence, 149, 117–121. https://doi.org/10.1016/j.drugalcdep.2015.01.027
  • WHO ASSIST Working Group. (2002). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction (Abingdon, England), 97(9), 1183–1194. https://doi.org/10.1046/j.1360-0443.2002.00185.x
  • Wu, M. A., Carnovale, C., Gabiati, C., Montori, D., & Brucato, A. (2021). Appropriateness of care: From medication reconciliation to deprescribing. Internal and Emergency Medicine, 16(8), 2047–2050. https://doi.org/10.1007/s11739-021-02846-1
  • Zelaya, C. E., Dahlhamer, J. M., Lucas, J. W., & Conner, E. M. (2020). Chronic pain and high-impact chronic pain among U.S. adults, 2019. NCHS Data Brief, no 390. National Center for Health Statistics

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.